- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01599091
Characterizing Gingival and Periodontal Ligament Fibroblasts Reaction to Infection With the Bacteria Porphyromonas Gingivalis
August 13, 2020 updated by: Hadassah Medical Organization
Characterizing Gingival and Periodontal Ligament Fibroblasts Reaction to Infection With the Perio- Pathogenic Bacteria Porphyromonas Gingivalis
Porphyromonas gingivalis is one of the major bacteria involved in the formation and progression of chronic periodontitis.
Pathogens invading the gingiva face the host's innate immune system at first and later on the acquired immune system which includes secreted antibodies and specialized cells.
Although both the arms of the immune system are coordinated to overcome the infection, there are several known mechanisms which help pathogens as Porphyromonas gingivalis evade immunity.
As a result, inflammatory mediators secreted by immune cells cause tissue damage and lead the inflammation process towards chronicity instead of clearing the pathogen.
Up till recently most of the studies focused on the role of macrophages, dendritic cells and lymphocytes at the response to periodontal pathogenic bacteria while the role of fibroblasts (the most abundant cell in the connective tissue) was less examined.
Fibroblasts are spindle shaped cells which have the ability to produce extra cellular matrix and respond to growth factors and cytokines.
They are able to affect cells in the infected tissue and contribute to immune response efficiency.
As known in the case of lymphocytes, fibroblasts also vary in subtypes, each differs in phenotype, immune interactions, extra cellular matrix production and destruction, migration abilities and so on.
Two main fibroblasts subtypes in the oral cavity originate in the gingival tissue and the periodontal ligament anchoring teeth to the surrounding alveolar bone.
Amongst the differences between the two are collagen production ability and receptors profile over the cell surface.
Considering all that, the investigators aim to obtain and use periodontal ligament and gingival tissues removed anyways during common dental procedures in order to extract the different fibroblasts subtypes residing there and compare their response to Porphyromonas gingivalis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jerusalem, Israel
- : Hadassah Medical Organization
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Healty over 18 years of age eligible for signing patients that go through tooth extraction for reasons not related to the study.
Description
Inclusion Criteria:
- Healthy men and women over 18 years of age, eligible for signing
- Patient in need for a tooth extraction regardless of the study
- Patient understanding and in consent to the character and the purpose of the study
- Patient with healthy gingival and connective tissue surrounding the tooth to be extracted
Exclusion Criteria:
- Pregnant or nursing women. children or non judgemental patients
- Patient undergoing tooth extraction due to periodontitis or any reason related to a problem in the tooth connective tissue
- patient with a Rontgenic bone loss around the tooth to be extracted.
- Patient with any oral disease other than gingivitis.
- Patients with need of pre-medication prior to invasive procedures.
- Patients with background disease or regular use of medications
- Patients treated with antibiotics in the 2 months preceding the tooth extraction.
- Smoking patients.
- Patients with alcohol abuse.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Fibroblast's donors
Patients undergoing tooth extraction will be asked permission to use the anyway extracted teeth and gingiva in order to harvest fibroblasts for further basic research.
|
Tooth extraction will be preformed in the regular way regardless of the study.
Patients will be asked permission to obtain the extracted tooth and excess of gingival remnants for further in vitro investigation in the main investigator's laboratory.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cytokines, inflammatory mediators and extracellular matrix proteins production and secretion in vitro by fibroblasts
Time Frame: primary outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
healthy patients undergoing tooth extraction will be asked permission to use the anyway extracted tooth and gingiva for basic laboratory research.
Periodontal ligament and gingival fibroblasts will be harvested from the collected specimens.
Protein production and secretion following in vitro stimulation of the fibroblasts with Porphyromonas gingivalis will be examined to assess their function during periodontal disease.
|
primary outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
RNA production in vitro
Time Frame: outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
RNA production following in vitro stimulation of fibroblasts with Porphyromonas gingivalis will be examined to assess their function during periodontal disease.
|
outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
|
cells motion in vitro
Time Frame: outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
fibroblasts and leukocytes (cell line) motion in vitro following co-culture and stimulation with Porphyromonas gingivalis will be examined to assess their function and interactions during periodontal disease
|
outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
|
Cytokines, inflammatory mediators and extracellular matrix proteins production and secretion by leukocyte cell lines in vitro
Time Frame: outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
fibroblasts and leukocytes (cell line) will be co-cultured with and without Porphyromonas gingivalis stimulation in vitro.
Protein production and secretion by leukocytes will be examined to assess their function and interactions with fibroblasts during periodontal disease
|
outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
|
RNA production in vitro by leukocyte cell lines
Time Frame: outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
fibroblasts and leukocytes (cell line) will be co-cultured with and without Porphyromonas gingivalis stimulation in vitro.
RNA production by leukocytes will be examined to assess their function and interactions with fibroblasts during periodontal disease
|
outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
|
Bacterial survival
Time Frame: outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
Porphyromonas gingivalis survival in vitro following incubation with fibroblasts and leukocytes cell lines (in mono or co-cultures ) will be examined to elucidate cells-bacterial interactions leading to periodontal disease chronicity.
|
outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
|
Bacterial adherence to fibroblasts and leukocytes in vitro
Time Frame: outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
Porphyromonas gingivalis in vitro adherance to fibroblasts and leukocytes cell lines (in mono or co-cultures ) will be examined to elucidate cells-bacterial interactions leading to periodontal disease chronicity.
|
outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
|
cell apoptosis (rate and speed)
Time Frame: outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
in vitro cell apoptosis (rate and speed) will be examined following stimulation with Porphyromonas gingivalis
|
outcome will be assessed in vitro within 15 years from specimen collection (basic research)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
May 3, 2012
First Submitted That Met QC Criteria
May 14, 2012
First Posted (Estimate)
May 15, 2012
Study Record Updates
Last Update Posted (Actual)
August 14, 2020
Last Update Submitted That Met QC Criteria
August 13, 2020
Last Verified
September 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GF-PDLF-0148-12-HMO-CTIL
- 0148-12-HMO (Other Identifier: Hadassah Medical Organization)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontal Disease
-
University of Roma La SapienzaActive, not recruitingPeriodontal Disease | Periodontal Disease, AVDC Stage 3 | Periodontal Disease Stage 2Italy
-
Tel Aviv UniversityRecruitingPeriodontal Disease | Periodontal Attachment Loss | Periodontal PocketsIsrael
-
Universitat Internacional de CatalunyaNot yet recruitingPresence of Periodontal Disease | Knowledge of Periodontal Disease
-
Ohio State UniversityNot yet recruitingPeriodontal Disease | Periodontal SurgeryUnited States
-
Siddharth ShanbhagUniversidad Complutense de MadridNot yet recruitingPeriodontal Disease | Intrabony Periodontal DefectsNorway, Spain
-
Massimo CorsaliniCompletedProbiotics And Ozonated Olive Oil To Maintain Oral Eubiosis In Stage I And II Periodontitis PatientsPeriodontal Disease | Periodontal Disease Stage 2Italy
-
University of BeykentCompletedPeriodontal Diseases | Periodontal Attachment Loss | Periodontal Inflammation | Periodontal Disease, AVDC Stage 3 | Periodontal Disease, AVDC Stage 4Turkey
-
Pierre Fabre Dermo CosmetiqueRecruitingPeriodontal DiseaseBelgium
-
Abant Izzet Baysal UniversityActive, not recruitingPeriodontal DiseaseTurkey (Türkiye)
-
251 Hellenic Air Force & VA General HospitalCompleted
Clinical Trials on Specimens collection
-
University of OxfordSanpasitthiprasong Hospital; Mahidol Oxford Tropical Medicine Research UnitCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Stand Up To CancerRecruitingHead and Neck Cancer | Lung Cancer | Gastrointestinal CancerUnited States
-
Northern Jiangsu People's HospitalCompleted
-
Children's Mercy Hospital Kansas CityUniversity of Kansas Medical CenterCompleted
-
The Stone Research Foundation for Sports Medicine...Completed
-
Vanderbilt UniversityElement DiagnosticsCompletedBladder Cancer, BiomarkersUnited States
-
University of Maryland, BaltimoreRecruitingDry Eye Disease | oGVHDUnited States
-
Peking University Third HospitalNot yet recruitingChronic Rhinosinusitis (CRS)China
-
Dartmouth-Hitchcock Medical CenterCompletedNon-Small Cell Lung CancerUnited States
-
Biomedical Advanced Research and Development AuthorityFred Hutchinson Cancer Center; AllucentActive, not recruitingCOVID-19United States